Login / Signup

Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?

Ji Sun BaekWan Ho LeeWoo Dae KangSeok Mo Kim
Published in: Obstetrics & gynecology science (2016)
Oral progestin therapy is an alternative treatment for women with CAH or G1EC who desire fertility preservation. However, more prospective studies are needed for standard progestin regimen. Also, there still remains a risk of disease progression and recurrence. Therefore, close follow-up is important during treatment and after CR. In addition, a hysterectomy is recommended as a definitive treatment after completion of childbearing.
Keyphrases
  • endometrial cancer
  • squamous cell carcinoma
  • combination therapy
  • replacement therapy